Signatures Health AI Clinical Intelligence Workspace
Logged in as demo_professional Logout

Clinical Conversation Orchestrator

A unified patient-specific conversation brief integrating cardiovascular clinical intelligence, ANSWERS evidence, medication and condition context, behavioral science, motivational interviewing, and professional communication priorities.

Communication boundary: This integrated brief is for patient-professional communication support only. It is not a diagnosis, treatment recommendation, triage tool, prescribing tool, or substitute for licensed clinical judgment.

Patient Story

Davis, Susan

Conditions

  • Atrial fibrillation
  • Diabetes
  • Hypertension
  • Prior stroke

Medications

  • Apixaban — standard , daily
  • Atorvastatin — standard , daily
  • Metoprolol — standard , daily

Demo narrative: This patient story is assembled from structured conditions, medications, symptoms, observations, and clinical intelligence modules to support a focused patient-professional conversation.

Active Intelligence Modules

hypertension lipids ckm atrial_fibrillation stroke

Condition List

  • Atrial fibrillation
  • Diabetes
  • Hypertension
  • Prior stroke

Medication List

  • Apixaban — standard , daily Demo clinical context
  • Atorvastatin — standard , daily Demo clinical context
  • Metoprolol — standard , daily Demo clinical context

Conversation Priorities

  • hypertension: Review BP pattern, medications, symptoms, and home/clinic monitoring.
  • lipids: Review LDL-C, triglycerides, Lp(a), ASCVD context, and lipid medication context.
  • ckm: Review CKM domains across BP, glucose, kidney, weight, lipids, and PREVENT.
  • atrial_fibrillation: Review AF symptoms, CHA2DS2-VASc context, and shared decision-making needs.
  • stroke: Review stroke/TIA history, neurologic symptoms, and secondary prevention context.

Integrated Summary

  • hypertension: No recent structured BP readings were found; consider whether home or clinic BP data are available.
  • lipids: No recent structured lipid observations were found; consider whether LDL-C, HDL-C, triglycerides, non-HDL-C, or Lp(a) data are available.
  • ckm: CKM-relevant condition domains detected: 3.
  • atrial_fibrillation: Atrial fibrillation or atrial flutter appears in the active condition context.
  • stroke: Potential neurologic symptom terms were detected: dizziness.

Patient Questions

  • What have you noticed about your blood pressure readings at home or during visits?
  • What usually makes it easier or harder to check your blood pressure?
  • What questions would you like to ask your clinician about blood pressure and heart health?
  • What questions do you have about cholesterol, heart risk, or your lab results?
  • What have you heard about LDL cholesterol, triglycerides, or Lp(a)?
  • What makes medication routines, nutrition changes, or follow-up lab testing easier or harder?
  • What questions do you have about how blood pressure, blood sugar, kidney health, weight, and heart health fit together?
  • What health numbers are easiest or hardest for you to track?
  • What would make it easier to follow up on labs, medications, home monitoring, or lifestyle goals?
  • What is one area you feel most ready to work on right now?

Motivational Interviewing Plan

  • Use open-ended questions to explore the patient's understanding of blood pressure and cardiovascular risk.
  • Listen for change talk, sustain talk, confidence, readiness, and barriers to self-monitoring or medication routines.
  • Reflect autonomy: the patient and professional can decide together what next step is realistic.
  • Affirm strengths such as tracking readings, asking questions, taking medications, or making lifestyle changes.
  • Listen for change talk and sustain talk around medications, diet, activity, weight, and follow-up testing.
  • Explore confidence and readiness before suggesting educational content.
  • Use reflective listening when the patient expresses confusion or concern about cholesterol numbers.
  • Affirm any existing strengths, such as completing labs, asking questions, taking medications, or tracking lifestyle goals.
  • Listen for change talk and sustain talk across BP monitoring, nutrition, activity, medication routines, and follow-up labs.
  • Explore readiness and confidence before choosing a next action.

Care Coordination Plan

  • Consider whether CKM context suggests coordination across primary care, cardiology, endocrinology, nephrology, pharmacy, nutrition, or cardiac rehabilitation.
  • Consider whether PREVENT, BP, lipid, glucose, kidney, and weight data should be reviewed together during the next professional encounter.
  • Consider whether the patient would benefit from a simplified explanation of how CKM domains interact.
  • Consider whether stroke context suggests coordination across neurology, primary care, cardiology, rehabilitation, pharmacy, speech therapy, occupational therapy, or nutrition.
  • Consider whether AF, BP, lipids, diabetes, CKM, and rehabilitation context should be reviewed together.
  • Consider whether symptoms should route to Hybrid Chat symptom workflow or professional work queue.

Evidence Summary

ModuleEvidenceOrganizationYearPriority
No prioritized evidence sources found yet.

Safety Reminders

  • This tool does not provide emergency triage or treatment decisions.
  • Medication changes should only be made by the licensed clinician or care team.
  • This tool does not set LDL-C targets, diagnose lipid disorders, or recommend medication changes.
  • Medication changes and interpretation of Lp(a) should be handled by the licensed clinician or care team.
  • Familial or markedly abnormal lipid patterns may warrant clinician-directed evaluation.
  • This tool does not assign official CKM stage or make treatment decisions.
  • Medication changes and interpretation of kidney, glucose, lipid, or PREVENT results should be handled by the licensed clinician or care team.
  • New or worsening symptoms should be reviewed by the professional work queue or appropriate clinical workflow.
  • This tool does not diagnose AF, triage acute symptoms, or recommend anticoagulation.
  • Anticoagulation, rate/rhythm, procedural, and monitoring decisions should be handled by the licensed clinician or care team.